| arachidonic acid metabolite production involved in inflammatory response | GO:0002538 | 2 | 0.683 | |
| leukotriene production involved in inflammatory response | GO:0002540 | 2 | 0.565 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.404 | |
| sphingolipid biosynthetic process | GO:0030148 | 26 | 0.376 | |
| phosphatidylethanolamine biosynthetic process | GO:0006646 | 2 | 0.363 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.331 | |
| adaptive immune response | GO:0002250 | 155 | 0.287 | |
| fatty acid derivative biosynthetic process | GO:1901570 | 15 | 0.276 | Human |
| ion transmembrane transport | GO:0034220 | 361 | 0.263 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.249 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.231 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.229 | Human |
| sensory perception of pain | GO:0019233 | 47 | 0.190 | |
| icosanoid biosynthetic process | GO:0046456 | 15 | 0.189 | Human |
| ceramide biosynthetic process | GO:0046513 | 20 | 0.185 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.184 | Human |
| regulation of cell activation | GO:0050865 | 289 | 0.171 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.160 | Human |
| organic acid transport | GO:0015849 | 101 | 0.157 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.156 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.154 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.152 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.146 | |
| inflammatory response | GO:0006954 | 244 | 0.146 | |
| regulation of cell motility | GO:2000145 | 236 | 0.141 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.137 | |
| coagulation | GO:0050817 | 78 | 0.134 | |
| ossification | GO:0001503 | 216 | 0.129 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.129 | |
| extracellular structure organization | GO:0043062 | 148 | 0.127 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.126 | |
| lipoxin a4 biosynthetic process | GO:2001303 | 1 | 0.125 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.124 | Human |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.121 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.119 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.112 | |
| lipid transport | GO:0006869 | 98 | 0.111 | |
| cytokine production | GO:0001816 | 319 | 0.111 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.110 | |
| membrane organization | GO:0061024 | 245 | 0.110 | |
| regulation of secretion | GO:0051046 | 274 | 0.108 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.107 | |
| organic anion transport | GO:0015711 | 137 | 0.107 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.103 | Human |
| wound healing | GO:0042060 | 157 | 0.103 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.103 | |
| synaptic transmission | GO:0007268 | 329 | 0.103 | |
| blood coagulation | GO:0007596 | 76 | 0.101 | |
| anion transport | GO:0006820 | 177 | 0.099 | |
| negative regulation of growth | GO:0045926 | 99 | 0.098 | |
| unsaturated fatty acid biosynthetic process | GO:0006636 | 15 | 0.098 | Human |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.097 | |
| phosphatidylethanolamine metabolic process | GO:0046337 | 2 | 0.097 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.093 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.090 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.090 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.089 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.089 | |
| icosanoid metabolic process | GO:0006690 | 33 | 0.088 | |
| cell adhesion | GO:0007155 | 329 | 0.088 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.088 | |
| female sex differentiation | GO:0046660 | 84 | 0.087 | |
| ceramide metabolic process | GO:0006672 | 31 | 0.087 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.086 | |
| t cell activation | GO:0042110 | 289 | 0.086 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.086 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.085 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.085 | |
| urogenital system development | GO:0001655 | 261 | 0.084 | |
| production of molecular mediator involved in inflammatory response | GO:0002532 | 21 | 0.083 | |
| response to hyperoxia | GO:0055093 | 2 | 0.083 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.082 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.082 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.081 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.081 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.080 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.080 | |
| leukotriene biosynthetic process | GO:0019370 | 5 | 0.079 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.079 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.074 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.074 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.074 | |
| gland development | GO:0048732 | 330 | 0.073 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.073 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.073 | |
| protein polymerization | GO:0051258 | 57 | 0.073 | |
| hemostasis | GO:0007599 | 78 | 0.072 | |
| cell chemotaxis | GO:0060326 | 81 | 0.068 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.067 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.066 | |
| homotypic cell cell adhesion | GO:0034109 | 28 | 0.066 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.066 | |
| microglia development | GO:0014005 | 2 | 0.065 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.064 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.064 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.064 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.064 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.063 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.063 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.062 | |
| intracellular protein transport | GO:0006886 | 204 | 0.061 | |
| fat cell differentiation | GO:0045444 | 160 | 0.060 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.060 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.059 | |
| regulation of cell migration | GO:0030334 | 219 | 0.059 | |
| response to nutrient levels | GO:0031667 | 109 | 0.059 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.058 | |
| amine metabolic process | GO:0009308 | 45 | 0.058 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.058 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.057 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.057 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.057 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.056 | |
| muscle tissue development | GO:0060537 | 308 | 0.054 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.054 | |
| response to peptide | GO:1901652 | 136 | 0.054 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.053 | |
| positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation | GO:2000721 | 2 | 0.053 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.053 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.052 | |
| interleukin 10 secretion | GO:0072608 | 4 | 0.052 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.052 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.051 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.051 | |
| regulation of defense response | GO:0031347 | 233 | 0.051 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.050 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.050 | |
| oxidation reduction process | GO:0055114 | 342 | 0.049 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.049 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.049 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.049 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.048 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.048 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.047 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.047 | |
| myotube differentiation | GO:0014902 | 105 | 0.047 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.046 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.046 | |
| sensory perception | GO:0007600 | 245 | 0.046 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.046 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.045 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.045 | |
| renal system development | GO:0072001 | 225 | 0.045 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.045 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.045 | |
| b cell activation | GO:0042113 | 161 | 0.044 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.044 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.044 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.043 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.043 | |
| lipoxygenase pathway | GO:0019372 | 5 | 0.043 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.042 | |
| tube formation | GO:0035148 | 140 | 0.042 | |
| cytokine secretion | GO:0050663 | 72 | 0.041 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.041 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.041 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.041 | |
| endomembrane system organization | GO:0010256 | 147 | 0.040 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.040 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.040 | |
| protein processing | GO:0016485 | 163 | 0.040 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.040 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.040 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.040 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.039 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.039 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.039 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.038 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.038 | |
| immune effector process | GO:0002252 | 321 | 0.038 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.038 | |
| response to calcium ion | GO:0051592 | 20 | 0.038 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.037 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.037 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.037 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.037 | |
| actin filament polymerization | GO:0030041 | 44 | 0.037 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.037 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.037 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.037 | |
| locomotory behavior | GO:0007626 | 195 | 0.037 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.037 | |
| phospholipid biosynthetic process | GO:0008654 | 36 | 0.037 | |
| transmembrane transport | GO:0055085 | 412 | 0.037 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.037 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.036 | |
| cellular response to calcium ion | GO:0071277 | 14 | 0.036 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.036 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.036 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.036 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.036 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.036 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.036 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.036 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.036 | |
| negative regulation of interleukin 10 secretion | GO:2001180 | 2 | 0.035 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.035 | |
| regulation of interleukin 10 secretion | GO:2001179 | 4 | 0.035 | |
| glial cell apoptotic process | GO:0034349 | 3 | 0.035 | |
| platelet aggregation | GO:0070527 | 20 | 0.035 | |
| response to inorganic substance | GO:0010035 | 96 | 0.034 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.034 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.033 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.033 | |
| muscle cell development | GO:0055001 | 133 | 0.033 | |
| stem cell differentiation | GO:0048863 | 268 | 0.033 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.033 | |
| regulation of tube size | GO:0035150 | 57 | 0.033 | |
| protein localization to organelle | GO:0033365 | 185 | 0.033 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.033 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.033 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.033 | |
| leukotriene metabolic process | GO:0006691 | 7 | 0.032 | |
| actin filament organization | GO:0007015 | 113 | 0.032 | |
| protein import into nucleus | GO:0006606 | 95 | 0.032 | |
| mapk cascade | GO:0000165 | 281 | 0.032 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.032 | |
| regulation of protein localization | GO:0032880 | 231 | 0.032 | |
| cytokine production involved in immune response | GO:0002367 | 34 | 0.032 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.032 | |
| skeletal system development | GO:0001501 | 356 | 0.031 | |
| protein ubiquitination | GO:0016567 | 171 | 0.031 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.031 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.031 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.031 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.031 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.031 | |
| phagocytosis | GO:0006909 | 66 | 0.031 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.031 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.031 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.031 | |
| cell junction organization | GO:0034330 | 77 | 0.031 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.031 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.030 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.030 | |
| tissue remodeling | GO:0048771 | 102 | 0.030 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.030 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.030 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.030 | Human |
| microglia differentiation | GO:0014004 | 2 | 0.030 | |
| glycerophospholipid biosynthetic process | GO:0046474 | 32 | 0.030 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.030 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.029 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.029 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.029 | |
| regulation of homotypic cell cell adhesion | GO:0034110 | 13 | 0.029 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.029 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.029 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.029 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.029 | |
| positive regulation of fever generation by positive regulation of prostaglandin secretion | GO:0071812 | 2 | 0.029 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.029 | |
| gtp metabolic process | GO:0046039 | 144 | 0.029 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.029 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.029 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.029 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.029 | |
| positive regulation of type 2 immune response | GO:0002830 | 9 | 0.029 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.028 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.028 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.028 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.028 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.028 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.028 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.028 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.028 | |
| cell cell junction organization | GO:0045216 | 72 | 0.028 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.028 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.027 | |
| granulocyte migration | GO:0097530 | 43 | 0.027 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.027 | |
| epithelial tube formation | GO:0072175 | 130 | 0.027 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.027 | |
| lipid localization | GO:0010876 | 126 | 0.027 | |
| b cell differentiation | GO:0030183 | 78 | 0.027 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.027 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.027 | |
| norepinephrine secretion | GO:0048243 | 2 | 0.027 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.027 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.027 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.027 | |
| gonad development | GO:0008406 | 141 | 0.027 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.027 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.027 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.026 | |
| cellular amino acid catabolic process | GO:0009063 | 25 | 0.026 | |
| amino acid transport | GO:0006865 | 61 | 0.026 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.026 | |
| amide transport | GO:0042886 | 138 | 0.026 | |
| regulation of system process | GO:0044057 | 200 | 0.026 | |
| regulation of cell growth | GO:0001558 | 91 | 0.026 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.026 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.025 | |
| synaptic vesicle localization | GO:0097479 | 59 | 0.025 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.025 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.025 | |
| kidney development | GO:0001822 | 213 | 0.025 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.025 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.025 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.025 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.025 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.025 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.024 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.024 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.024 | |
| negative regulation of cell substrate adhesion | GO:0010812 | 16 | 0.024 | |
| response to peptide hormone | GO:0043434 | 127 | 0.024 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.024 | |
| regulation of norepinephrine secretion | GO:0014061 | 2 | 0.024 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.024 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.024 | |
| thymocyte migration | GO:0072679 | 2 | 0.024 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.024 | |
| cation transport | GO:0006812 | 399 | 0.024 | |
| neurotransmitter secretion | GO:0007269 | 62 | 0.023 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 32 | 0.023 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.023 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.023 | |
| striated muscle cell development | GO:0055002 | 125 | 0.023 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.023 | |
| glial cell differentiation | GO:0010001 | 131 | 0.023 | |
| bone mineralization | GO:0030282 | 54 | 0.023 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.023 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.023 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.023 | |
| cartilage development | GO:0051216 | 140 | 0.023 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.023 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.023 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.023 | |
| platelet activation | GO:0030168 | 40 | 0.023 | |
| regulation of water loss via skin | GO:0033561 | 16 | 0.023 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.023 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.022 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.022 | |
| protein maturation | GO:0051604 | 176 | 0.022 | |
| connective tissue development | GO:0061448 | 179 | 0.022 | |
| circadian temperature homeostasis | GO:0060086 | 2 | 0.022 | |
| regionalization | GO:0003002 | 337 | 0.022 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.022 | |
| spermatogenesis | GO:0007283 | 284 | 0.022 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.022 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.022 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.022 | |
| defense response to virus | GO:0051607 | 68 | 0.022 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.022 | |
| neuron death | GO:0070997 | 154 | 0.022 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.022 | |
| lung cell differentiation | GO:0060479 | 30 | 0.021 | |
| leukocyte migration | GO:0050900 | 124 | 0.021 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.021 | |
| forebrain development | GO:0030900 | 302 | 0.021 | |
| t cell proliferation | GO:0042098 | 120 | 0.021 | |
| positive regulation of lymphocyte differentiation | GO:0045621 | 61 | 0.021 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.021 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.021 | |
| protein lipidation | GO:0006497 | 28 | 0.021 | |
| tube closure | GO:0060606 | 91 | 0.021 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.021 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.021 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.021 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.021 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.021 | |
| protein catabolic process | GO:0030163 | 221 | 0.021 | |
| norepinephrine transport | GO:0015874 | 2 | 0.021 | |
| nephron epithelium development | GO:0072009 | 92 | 0.021 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.021 | |
| regulation of eosinophil migration | GO:2000416 | 2 | 0.020 | |
| neuron neuron synaptic transmission | GO:0007270 | 69 | 0.020 | |
| response to growth factor | GO:0070848 | 198 | 0.020 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.020 | |
| hair cycle | GO:0042633 | 90 | 0.020 | |
| epidermis development | GO:0008544 | 187 | 0.020 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.020 | |
| acid secretion | GO:0046717 | 33 | 0.020 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.020 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.020 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.020 | |
| innate immune response | GO:0045087 | 157 | 0.020 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.020 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.020 | |
| ureteric bud development | GO:0001657 | 94 | 0.020 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.020 | |
| calcium ion transport | GO:0006816 | 159 | 0.020 | |
| regulation of phagocytosis engulfment | GO:0060099 | 5 | 0.020 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.020 | |
| dendritic spine maintenance | GO:0097062 | 4 | 0.019 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.019 | |
| negative regulation of alpha beta t cell activation | GO:0046636 | 18 | 0.019 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.019 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.019 | |
| positive regulation of production of molecular mediator of immune response | GO:0002702 | 45 | 0.019 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.019 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.019 | |
| regulation of cell size | GO:0008361 | 72 | 0.019 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.019 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.019 | |
| protein homotrimerization | GO:0070207 | 4 | 0.019 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.019 | |
| positive regulation of alpha beta t cell differentiation | GO:0046638 | 28 | 0.019 | |
| camera type eye development | GO:0043010 | 266 | 0.019 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.019 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.019 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.019 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.019 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.019 | |
| regeneration | GO:0031099 | 38 | 0.019 | |
| female gonad development | GO:0008585 | 71 | 0.019 | |
| nephron development | GO:0072006 | 109 | 0.019 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.019 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.018 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.018 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.018 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.018 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.018 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.018 | |
| germ cell development | GO:0007281 | 185 | 0.018 | |
| plasma membrane organization | GO:0007009 | 90 | 0.018 | |
| acute inflammatory response | GO:0002526 | 41 | 0.018 | |
| endocytosis | GO:0006897 | 168 | 0.018 | |
| cell cell recognition | GO:0009988 | 44 | 0.018 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.018 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.018 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.018 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.018 | |
| positive regulation of nf kappab transcription factor activity | GO:0051092 | 30 | 0.018 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.018 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.018 | Zebrafish |
| maintenance of location | GO:0051235 | 89 | 0.018 | |
| male gamete generation | GO:0048232 | 285 | 0.018 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.018 | |
| negative regulation of coagulation | GO:0050819 | 11 | 0.018 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.018 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.017 | |
| regulation of protein transport | GO:0051223 | 163 | 0.017 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.017 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.017 | |
| establishment of skin barrier | GO:0061436 | 14 | 0.017 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.017 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.017 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.017 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.017 | |
| rhythmic process | GO:0048511 | 174 | 0.017 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.017 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.017 | |
| nuclear transport | GO:0051169 | 139 | 0.017 | |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.017 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.017 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.017 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.017 | |
| single fertilization | GO:0007338 | 82 | 0.017 | |
| icosanoid secretion | GO:0032309 | 12 | 0.017 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.017 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.017 | |
| regulation of thymocyte migration | GO:2000410 | 2 | 0.017 | |
| chemokine production | GO:0032602 | 34 | 0.017 | |
| trunk neural crest cell migration | GO:0036484 | 4 | 0.017 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.017 | |
| regulation of interleukin 6 production | GO:0032675 | 55 | 0.017 | |
| cognition | GO:0050890 | 149 | 0.017 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.017 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.017 | |
| interleukin 6 production | GO:0032635 | 58 | 0.017 | |
| male gonad development | GO:0008584 | 88 | 0.017 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.017 | |
| compound eye development | GO:0048749 | 1 | 0.017 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.017 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.017 | |
| lung development | GO:0030324 | 164 | 0.017 | |
| positive regulation of killing of cells of other organism | GO:0051712 | 3 | 0.017 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.017 | |
| interleukin 8 production | GO:0032637 | 4 | 0.017 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.017 | |
| regulation of alpha beta t cell differentiation | GO:0046637 | 35 | 0.017 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.017 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.016 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.016 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.016 | |
| regulation of cytokine secretion involved in immune response | GO:0002739 | 4 | 0.016 | |
| respiratory tube development | GO:0030323 | 167 | 0.016 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.016 | |
| negative regulation of wound healing | GO:0061045 | 14 | 0.016 | |
| bone resorption | GO:0045453 | 38 | 0.016 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.016 | |
| response to steroid hormone | GO:0048545 | 56 | 0.016 | |
| positive regulation of alpha beta t cell activation | GO:0046635 | 39 | 0.016 | |
| cell growth | GO:0016049 | 130 | 0.016 | |
| response to increased oxygen levels | GO:0036296 | 2 | 0.016 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.016 | |
| neutrophil chemotaxis | GO:0030593 | 36 | 0.016 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.016 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.016 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.016 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.016 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.016 | |
| protein localization to membrane | GO:0072657 | 108 | 0.016 | |
| response to radiation | GO:0009314 | 165 | 0.016 | |
| response to insulin | GO:0032868 | 100 | 0.016 | |
| protein targeting | GO:0006605 | 143 | 0.016 | |
